%0 Journal Article
%T Gene expression in cardiac tissues from infants with idiopathic conotruncal defects
%A Douglas C Bittel
%A Merlin G Butler
%A Nataliya Kibiryeva
%A Jennifer A Marshall
%A Jie Chen
%A Gary K Lofland
%A James E O'Brien
%J BMC Medical Genomics
%D 2011
%I BioMed Central
%R 10.1186/1755-8794-4-1
%X We employed genome wide gene expression microarrays to characterize cardiovascular tissue (right ventricle, pulmonary valve and pulmonary artery) obtained at the time of reconstructive surgery from 19 children with TOF (16 idiopathic and three with 22q11.2 deletions) and compared gene expression patterns to normally developing subjects.We detected a signal from approximately 26,000 probes reflecting expression from about half of all genes, ranging from 35% to 49% of array probes in the three tissues. More than 1,000 genes had a 2-fold change in expression in the right ventricle (RV) of children with TOF as compared to the RV from matched control infants. Most of these genes were involved in compensatory functions (e.g., hypertrophy, cardiac fibrosis and cardiac dilation). However, two canonical pathways involved in spatial and temporal cell differentiation (WNT, p = 0.017 and Notch, p = 0.003) appeared to be generally suppressed.The suppression of developmental networks may represent a remnant of a broad malfunction of regulatory pathways leading to inaccurate boundary formation and improper structural development in the embryonic heart. We suggest that small tissue specific genomic and/or epigenetic fluctuations could be cumulative, leading to regulatory network disruption and failure of proper cardiac development.The heart is the first major internal organ to form during embryogenesis, and its circulatory function is critical early on for the viability of the embryo. The development of integrated cardiovascular tissue is the result of multiple cell to cell interactions involving temporal and spatial events under genetic control. Failure of proper cellular differentiation, migration and apoptosis results in congenital heart disease (CHD), which is a major cause of childhood morbidity and death and remains a substantial challenge even in countries with advanced health care systems. The incidence of CHD is approximately eight per 1000 live births [1] making CHD the m
%U http://www.biomedcentral.com/1755-8794/4/1